Debanjana Chatterjee
Stock Analyst at JonesTrading
(4.94)
# 151
Out of 4,646 analysts
245
Total ratings
66.1%
Success rate
45.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debanjana Chatterjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics | Maintained: Buy | $29 | $11.83 | +145.14% | 28 | Aug 14, 2026 | |
| TRVI Trevi Therapeutics | Rated: Buy | $24 → $28 | $18.15 | +54.27% | 22 | Aug 13, 2026 | |
| ATHE Alterity Therapeutics | Maintained: Buy | $16 | $4.70 | +240.43% | 3 | Aug 12, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | $104 → $140 | $101.85 | +37.46% | 19 | Aug 12, 2026 | |
| ABSI Absci | Maintained: Buy | $13 | $9.46 | +37.42% | 19 | Aug 12, 2026 | |
| TVRD Tvardi Therapeutics | Maintained: Buy | $12 | $1.77 | +577.97% | 17 | Aug 10, 2026 | |
| ABCL AbCellera Biologics | Reiterated: Buy | $13 → $25 | $10.97 | +127.89% | 8 | Aug 10, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | $63 | $6.54 | +863.30% | 9 | Aug 10, 2026 | |
| EYPT EyePoint | Maintained: Buy | $43 | $13.48 | +218.99% | 27 | Aug 5, 2026 | |
| CTNM Contineum Therapeutics | Reiterated: Buy | $26 | $15.30 | +69.93% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.73 | +168.10% | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.39 | +259.71% | 2 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $9.28 | +234.05% | 17 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 → $17 | $16.92 | +0.47% | 12 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 | $34.04 | +52.76% | 13 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.82 | +314.94% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.03 | - | 8 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.21 | +211.44% | 3 | May 8, 2026 |
Intellia Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $29
Current: $11.83
Upside: +145.14%
Trevi Therapeutics
Aug 13, 2026
Rated: Buy
Price Target: $24 → $28
Current: $18.15
Upside: +54.27%
Alterity Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $16
Current: $4.70
Upside: +240.43%
Spyre Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $104 → $140
Current: $101.85
Upside: +37.46%
Absci
Aug 12, 2026
Maintained: Buy
Price Target: $13
Current: $9.46
Upside: +37.42%
Tvardi Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $12
Current: $1.77
Upside: +577.97%
AbCellera Biologics
Aug 10, 2026
Reiterated: Buy
Price Target: $13 → $25
Current: $10.97
Upside: +127.89%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: $63
Current: $6.54
Upside: +863.30%
EyePoint
Aug 5, 2026
Maintained: Buy
Price Target: $43
Current: $13.48
Upside: +218.99%
Contineum Therapeutics
Jul 31, 2026
Reiterated: Buy
Price Target: $26
Current: $15.30
Upside: +69.93%
Jul 30, 2026
Maintained: Buy
Price Target: $10
Current: $3.73
Upside: +168.10%
Jul 23, 2026
Maintained: Buy
Price Target: $5
Current: $1.39
Upside: +259.71%
Jul 21, 2026
Maintained: Buy
Price Target: $31
Current: $9.28
Upside: +234.05%
Jun 29, 2026
Downgraded: Hold
Price Target: $19 → $17
Current: $16.92
Upside: +0.47%
Jun 11, 2026
Maintained: Buy
Price Target: $52
Current: $34.04
Upside: +52.76%
May 27, 2026
Reiterated: Buy
Price Target: $20
Current: $4.82
Upside: +314.94%
May 22, 2026
Rated: Hold
Price Target: n/a
Current: $0.03
Upside: -
May 8, 2026
Maintained: Buy
Price Target: $10
Current: $3.21
Upside: +211.44%